Eight-week moclobemide pharmacotherapy improves clinical but not cognitive outcomes in social anxiety disorder

Lian Taljaard; Alex Doruyter; Dan Joseph Stein; Christine Löchner

doi:10.1016/s0924-977x(17)31768-6

Back

Eight-week moclobemide pharmacotherapy improves clinical but not cognitive outcomes in social anxiety disorder

Article 2017 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2017

Pharmacotherapy for social anxiety disorder (SAnD)

Taryn Williams, Coenie Hattingh, Catherine M Kariuki, S. Tromp, Anton J.L.M. van Balkom, Jonathan Ipser, Dan Joseph Stein

Article2010

Combined Pharmacotherapy and Psychotherapy for Social Anxiety Disorder

Dan Joseph Stein, Jonathan Ipser

Article2017

Resting regional brain metabolism in social anxiety disorder and the effect of moclobemide therapy

Alex Doruyter, Patrick Dupont, Lian Taljaard, Dan Joseph Stein, Christine Löchner, James Warwick

Article2016

Resting functional connectivity in social anxiety disorder and the effect of pharmacotherapy

Alex Doruyter, Christine Löchner, Gerhard P. Jordaan, Dan Joseph Stein, Patrick Dupont, James Warwick

Article2010

A 2010 Evidence-Based Algorithm for the Pharmacotherapy of Social Anxiety Disorder

Dan Joseph Stein, David S. Baldwin, Borwin Bandelow, Carlos Blanco, Leonardo F. Fontenelle, Sing Lee, Hisato Matsunaga, David N. Osser, Murray B. Stein, Michael Van Ameringen